Every Form 4 that AstraZeneca (AZN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AZN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AZN filings page.
AstraZeneca PLC reported that SVP, Group Controller Mani Sharma acquired 2.0000 Ordinary Shares on August 6, 2026 through a non-derivative grant under the Issuer's Share Incentive Plan. The shares were priced at GBP121.26 ($163.3400) using a GBP1.0000 to $1.3470 conversion rate, bringing direct holdings to 19267.4659 shares.
AstraZeneca PLC officer Mani Sharma reported a small share-based compensation award. On July 6, 2026, Sharma acquired 2 Ordinary Shares in a grant/award transaction at $190.43 per share, linked to the company’s Share Incentive Plan at GBP142.492 per share. The price was converted using a GBP1.0000 to $1.3364 rate published on July 2, 2026. After this award, Sharma directly holds 19,265.4659 Ordinary Shares, reflecting a routine compensation-related acquisition rather than an open-market purchase.
AstraZeneca PLC officer Mani Sharma acquired 1 Ordinary Share as a compensation grant under the company’s Share Incentive Plan. The award was valued at $179.75 per share, based on a GBP134.54 price converted at a GBP1.0000 to $1.3360 rate. Following this grant, Sharma directly holds 19,263.4659 AstraZeneca Ordinary Shares.
ASTRAZENECA PLC officer Sharma Mani reported an open-market sale of 11,893 Ordinary Shares on May 20, 2026 at an average price of $185.78 per share, based on a GBP139.35 price and a stated currency conversion rate. After this transaction, Mani directly holds 19,262.4659 Ordinary Shares.
AstraZeneca PLC officer Sharma Mani reported routine share awards under the company’s Share Incentive Plan. On April 7, 2026, Mani acquired 1 Ordinary Share at $196.03, and on May 6, 2026, acquired 1 Ordinary Share at $186.28, both as grants rather than open-market purchases.
After these awards, Mani directly held a total of 31,155.4659 Ordinary Shares. The award prices reflect conversions from GBP148.06 and GBP136.76 using Federal Reserve exchange rates published in April and May 2026.